Design, Synthesis and Biological Activity of 4,6-disubstituted Pyridin-2(1H)-ones as Novel Inhibitors of Soluble Epoxide Hydrolase

Document Type : Research article


Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Soluble epoxide hydrolase enzyme is a promising therapeutic target for hypertension, vascular inflammation, pain and some other risk factors of cardiovascular diseases. The most potent sEH inhibitors reported in the literature are urea-based ones which often have poor bioavailability. In this study, in a quest for finding potent inhibitors of soluble epoxide hydrolase, some 4,6-disubstituted pyridin-2(1H)-one derivatives were designed and synthesized. The designed compounds fit properly in the active site pocket of this enzyme in docking studies and have appropriate distances for effective hydrogen binding to important amino acids Tyr383, Tyr466, and Asp335. The results of biological evaluation of these compounds against soluble epoxide hydrolase enzyme indicate most compounds have acceptable inhibitory activity and compound 9c is the most potent inhibitor with inhibitory activity of 86%.


Main Subjects

Greene JF, Newman JW, Williamson KC and
Hammock BD. Toxicity of epoxy fatty acids and
related compounds cells expressing human soluble
epoxide hydrolase. Chem. Res. Toxicol. (2000) 13:
Newman JW, Morisseau C and Hammock BD.
Epoxide hydrolases: Their roles and interactions with
lipid metabolism . Prog. Lipid. Res. (2005) 44: 1–51.
Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend
JR and Gonzalez FJ. Targeted disruption of soluble
epoxide hydrolase reveals a role in blood pressure
regulation. J. Biol. Chem. (2000) 275: 40504–10.
Decker M, Arand M and Cronin A. Mammalian
epoxide hydrolases in xenobiotic metabolism and
signalling. Arch. Toxicol. (2009) 83: 297–318.
Morisseau C and Hammock BD. Gerry Brooks and
epoxide hydrolases: Four decades to a pharmaceutical.
Pest Manag. Sci. (2008) 64: 594–609.
Marowsky A, Burgener J, Falck JR, Fritschy JM and
Arand M. Distribution of soluble and microsomal
epoxide hydrolase in the mouse brain and its
contribution to cerebral epoxyeicosatrienoic acid
metabolism. Neuroscience (2009) 163: 646–61.
Okin D and Medzhitov R. Evolution of inflammatory
diseases. Curr. Biol. (2012) 22: 733–40.
Kiani A, Rezaee E and Tabatabai SA. Novel group
of imidazole derivatives as atypical selective
cyclooxygenase-2 inhibitors: design, synthesis and
biological evaluation. Iran. J. Pharm. Res. (2018) 17:
Morisseau C, Goodrow MH, Dowdy D, Zheng J,
Greene JF, Sanborn JR and Hammock BD. Potent
urea and carbamate inhibitors of soluble epoxide
hydrolases. Proc. Natl. Acad. Sci. (1999) 96: 8849–54.
Zavareh E, Hedayati M, Rad L, Kiani A, Shahhosseini
S, Faizi M and Tabatabai SA. Design, synthesis and
biological evaluation of some oxadiazole derivatives
as novel amide-based inhibitors of soluble epoxide
hydrolase. Lett. Drug Des. Discov. (2014) 11: 721–30.
Rezaee Zavareh E, Hedayati M, Hoghooghi Rad
L, Shahhosseini S, Faizi M and Tabatabai SA.
Design, synthesis and biological evaluation of
4-benzamidobenzoic acid hydrazide derivatives as
novel soluble epoxide hydrolase inhibitors. Iran. J.
Pharm. Res. (2014) 13: 51–9.
Rezaee E, Hedayati M, Rad LH, Shahhosseini S,
Faizi M and Tabatabai SA. Novel soluble epoxide
hydrolase inhibitors with a dihydropyrimidinone
scaffold: Design, synthesis and biological evaluation.
Med. Chem. Commun. (2016) 7: 2128–35.
Morris GM, Ruth H, Lindstrom W, Sanner MF, Belew
RK, Goodsell DS and Olson AJ. Software news and
updates AutoDock4 and AutoDockTools4: Automated
docking with selective receptor flexibility. J. Comput.
Chem. (2009) 30: 2785–91.
Trott O and Olson AJ. Software news and update
AutoDock Vina: Improving the speed and accuracy
of docking with a new scoring function, efficient
optimization, and multithreading. J. Comput. Chem.
(2010) 31: 455–61.
Weiner SJ, Kollman PA, Singh UC, Case DA, Ghio C,
Alagona G, Profeta S and Weiner P. A new force field
for molecular mechanical simulation of nucleic acids
and proteins. J. Am. Chem. Soc. (1984) 106: 765–84.
Nosova GI, Rtishchev NI, Solovskaya NA,
Dobrodumov AV, Lukyashina VA and Kudryavtsev
VV. Phototransformations of phthalamido derivatives
of chalcones. Russ. J. Gen. Chem. (1997) 67: 618–26.
Albrecth O, Frei J and Sallmann R. Zur kenntnis
der umsetzung von methylol-carbonsäureamiden und deren funktionellen derivaten mit
hydroxylverbindungen. Helv. Chim. Acta (1941) 24:
Lima L and Barreiro E. Bioisosterism: a useful strategy
for molecular modification and drug design. Curr.
Med. Chem. (2012) 12: 23–49.
Binder D, Hromatka O, Geissler F, Schmied K,
Noe CR, Burri K, Pfister R, Strub K and Zeller P.
Analogues and derivatives of tenoxicam. 1. Synthesis
and antiinflammatory activity of analogues with
different residues on the ring nitrogen and the amide
nitrogen. J. Med. Chem. (1987) 30: 678–82.